Cerebrospinal Fluid Metabolomics: Pilot Study of Using Metabolomics to Assess Diet and Metabolic Interventions in Alzheimer’s Disease and Mild Cognitive Impairment

Brain glucose hypometabolism is an early sign of Alzheimer’s disease (AD), and interventions which offset this deficit, such as ketogenic diets, show promise as AD therapeutics. Conversely, high-fat feeding may exacerbate AD risk. We analyzed the metabolomic profile of cerebrospinal fluid (CSF) in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanson, Angela J., Banks, William A., Bettcher, Lisa F., Pepin, Robert, Raftery, Daniel, Navarro, Sandi L., Craft, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145981/
https://www.ncbi.nlm.nih.gov/pubmed/37110227
http://dx.doi.org/10.3390/metabo13040569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145981/
https://www.ncbi.nlm.nih.gov/pubmed/37110227
http://dx.doi.org/10.3390/metabo13040569

Ejemplares similares